Year: 2023

NEW YORK, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –Image Protect Inc. (OTC:IMTL) (Imageprotectcorporation.com) (“Image Protect” or the “Company”), is pleased to announce that its new subsidiary Review Control™ Reputation Management has released its newest product, ProfileControl™. This is the next in a series of new products being added to the lineup of outstanding business tools created to increase visibility and supercharge the reputation and footprint of clients and increase revenue for the Company. New ProfileControl™ creates and manages a business’s profile across 60 plus leading Websites and monitors for inaccurate information. In addition, ProfileControl™ allows businesses to update their information across the web within a single easy to use interface with outstanding accuracy at...

TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its quarter ended September 30th, 2023, after market close on November 9th, 2023. The Company will subsequently hold a conference call via Zoom on November 10th, 2023, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow. To register for the conference call please visit: https://us02web.zoom.us/webinar/register/WN_xaGInaLgTjmtaG7YBfONJA ABOUT VITALHUB: Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes. VitalHub provides technology to Health and Human Services providers including Hospitals, Regional Health Authorities, Mental Health, Long Term Care,...

VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedelic substances such as MDMA and high-quality, GMP-grade natural psilocybin, is pleased to announce it has entered into a non-dilutive Debt Financing Agreement (“DFA”) and General Security Agreement (“GSA”) for total proceeds of CAD$1,000,000 (the “Loan”) from one arm’s length party (the “Lender”). Pursuant to the DFA and the GSA, the Loan is secured against the assets of the Company and will bear interest at a rate of 7.5% per annum, payable by the Company to the Lender quarterly on the last business day of every fiscal quarter until full repayment. Upon maturity of the Loan, all...

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial-stage targeted oncology company, today announced a clinical collaboration and supply agreement to evaluate the combination of KO-2806, a next-generation farnesyl transferase inhibitor (FTI), and adagrasib, a highly selective KRASG12C inhibitor, in patients with KRASG12C-mutated non-small cell lung cancer (NSCLC). “Recent findings suggest that combining KO-2806 with adagrasib can drive tumor regressions and enhance both duration...

– Targeting ADC and Cell & Gene Therapy Customers – WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device. The technology is especially suited to the manufacture of biologics where fully closed systems are critical or ideal, including antibody drug conjugates (ADCs), viral vectors, nucleic acids and lipid nanoparticles, and can also be applied to monoclonal antibody, and recombinant protein production. TangenX SC is not only transformative, it is also a milestone achievement in the advancement of downstream flat sheet TFF technology for ultrafiltration and diafiltration...